US2007014870A1PendingUtilityA1

Compositions for regenerating defective or absent myocardium

Assignee: CORMATRIX CARDIOVASCULAR INCPriority: Jul 15, 2005Filed: Mar 2, 2006Published: Jan 18, 2007
Est. expiryJul 15, 2025(expired)· nominal 20-yr term from priority
A61L 2400/06A61K 31/7088A61K 35/407A61L 2300/426A61L 2430/30A61K 35/34A61K 38/1825A61L 27/3683A61L 27/3873A61K 9/0019A61K 48/00A61L 2430/20A61L 27/367A61K 35/50A61L 2300/412A61K 35/37A61L 2300/414A61K 38/1841A61K 35/38A61K 38/39A61L 27/3633A61K 35/545A61L 27/227A61L 27/3687A61L 27/58A61L 27/3629A61K 31/726A61K 35/22A61L 27/3834A61L 27/54A61L 2300/45A61L 2300/64A61K 38/1741A61L 27/40A61K 35/28A61K 31/711A61K 31/7105A61L 27/3804
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition can also have an extracellular matrix scaffold component of any formulation, then including also added cells, proteins, or other components to optimize the regenerative process and restore cardiac function. Methods for regenerating defective or absent myocardium apply a composition to a site of myocardium in need of regeneration using a delivery mode appropriate for the particular formulation.

Claims

exact text as granted — not AI-modified
1 - 26 . (canceled)  
     
     
         27 . A method of recruiting sufficient stem cells to a site of defect in myocardium to induce a process selected from the group consisting of phenotypic changes in the recruited stem cells, establishment of cell-cell connections, establishment of vascular supply to the site, establishment of normal tissue specific metabolism, coupling electrical conduction from new cells to existing cells and pathways, establishment of cell-extracellular matrix connections by way of cell-adhesion to matrix proteins in the extracellular matrix, establishment of protein-cell connections, protein-protein interactions which lead to organizing the cells into tissues, temporary cell adhesion processes as a result of embryogenesis of the recruited cells, morphogenesis of the cells, and maintenance of differentiated cells, said method comprising contacting the defect in myocardium with a sufficient amount of extracellular matrix material, wherein when the defect is contacted with sufficient extracellular matrix material and upon sufficient stem cell recruitment, new myocardial tissue is formed restoring cardiac function.  
     
     
         28 . A method as in  claim 27 , wherein the extracellular matrix is mammalian extracellular matrix.  
     
     
         29 . A method as in  claim 27 , wherein the extracellular matrix is an emulsion, injectable, liquid, gel, or paste.  
     
     
         30 . A method as in  claim 27 , wherein the extracellular matrix is formulated in a material form selected from the group consisting of a solid sheet, multilaminate sheets, a powder, a plug, a strand, a suture, a coil, a cylinder, a weave, a strip, a spray, a vapor, a patch, a sponge, a cream, and a coating.  
     
     
         31 . A method as in  claim 28 , wherein the mammalian extracellular matrix is selected from the group consisting of small intestine submucosa (SIS), urinary bladder submucosa (UBS), urinary basement membrane (UBM), liver basement membrane (LBM), stomach submucosa (SS), collagen from animal sources, collagen from plant sources, synthesized extracellular matrix in cultures from cells (Matrigel™), dermal extracellular matrix material, subcutaneous extracellular matrix material, large intestine extracellular matrix material, placental extracellular matrix material, ornamentum extracellular matrix material, heart extracellular matrix material, and lung extracellular matrix material.  
     
     
         32 . The method of  claim 27 , wherein the contacting step comprises delivering the extracellular matrix by a delivery means selected from the group consisting of injecting, suturing, stapling, injecting with a percutaneous catheter, CO 2  powering emission of fine emulsion, micronizing an injectable solution, ink jet delivery, physically depositing a sponge, physically depositing a patch, physically depositing a strip, and physically depositing a formed scaffold of any shape.  
     
     
         33 . A method of accomplishing myocardial tissue regeneration and restoring cardiac function at a site of defect in myocardial tissue by triggering protein activation and activation of nearby cells in the defective myocardial tissue comprising contacting the defective myocardial tissue with sufficient extracellular matrix material having functional proteins that interact with structural proteins and migrating or recruited stem cells, wherein upon contact with sufficient extracellular matrix material new myocardial tissue is formed restoring cardiac function, and no exogenous agents or stimulus are applied to accomplish the myocardial tissue regeneration and restoration of function.

Join the waitlist — get patent alerts

Track US2007014870A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.